Key result
Intravenous amiodarone produced rapid and significant decreases in mean aortic pressure and cardiac output that persisted throughout the 6-hour maintenance infusion, driven by its cosolvents.
Why the study?
Does intravenous amiodarone cause sustained hypotension during the maintenance infusion period in anaesthetized beagle dogs?
Does intravenous amiodarone cause sustained hypotension during the maintenance infusion period in anaesthetized beagle dogs?
The sustained hypotensive and cardiodepressant effects of intravenous amiodarone during maintenance infusion are caused by its cosolvents rather than the active drug itself.
Answers are grounded in this paper and cite their sources.
Cosolvents may drive amiodarone-related hemodynamic effects in dogs; leaves open relevance to human intravenous use.
Hypotension frequently occurs with use of intravenous amiodarone and is managed by slowing the rate of administration. This response has been attributed to the cosolvents in the formulation and is believed to be solely related to the initial loading dose. The present study was performed to determine whether intravenous amiodarone-induced hypotension persists beyond the loading dose and into the maintenance infusion period and also whether hypotension occurs with maintenance level dosing alone. 2. Anaesthetized beagle dogs (n = 7/group) were instrumented to assess haemodynamics. Animals were treated with the human-equivalent dosing regimen (loading dose followed by maintenance infusion) of intravenous amiodarone or control (5% dextrose in water). 3. No haemodynamic changes were observed in the control group during the 6 h study. In contrast, administration of the standard intravenous amiodarone regimen produced rapid and significant decreases in mean aortic pressure, cardiac output and maximum rate of change of left ventricular pressure that persisted throughout the 6 h maintenance infusion period. Administration of amiodarone as the maintenance infusion dose alone produced haemodynamic changes that were similar in magnitude to those observed with administration of the full dosing regimen, but were delayed in onset by approximately 60 min. 4. Dosing with a cosolvent-free formulation of amiodarone (PM101) caused no haemodynamic effects during the 6 h dosing period, indicating that the cardiodepressant effects of intravenous amiodarone were due to its cosolvents. 5. These data suggest that consideration should be given to intravenous amiodarone as a potential cause for sustained hypotension during prolonged infusion.
No takes yet. Share an insight, caveat, or question.
Cushing et al. (2009) studied Haemodynamic assessment in anaesthetized beagle dogs. Intravenous amiodarone vs. 5% dextrose in water was evaluated on Haemodynamic changes (mean aortic pressure, cardiac output, maximum rate of change of left ventricular pressure). Intravenous amiodarone produced rapid and significant decreases in mean aortic pressure and cardiac output that persisted throughout the 6-hour maintenance infusion, driven by its cosolvents.
Synapse has enriched 10 related papers. Consider them for comparative context: